Search Results

There are 19512 results for: content related to: Comparative safety of selective serotonin reuptake inhibitors among pediatric users with respect to adverse cardiac events

  1. Escitalopram versus other antidepressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Claudio Santilli, Toshi A Furukawa, Alessandra Signoretti, Atsuo Nakagawa, Hugh McGuire, Rachel Churchill and Corrado Barbui

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD006532.pub2

  2. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery

    Intervention Review

    The Cochrane Library

    Gillian E Mead, Cheng-Fang Hsieh, Rebecca Lee, Mansur A Kutlubaev, Anne Claxton, Graeme J Hankey and Maree L Hackett

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD009286.pub2

  3. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction

    The Journal of Sexual Medicine

    Volume 12, Issue 10, October 2015, Pages: 2036–2048, Paula L. Jacobsen, Atul R. Mahableshwarkar, Yinzhong Chen, Lambros Chrones and Anita H. Clayton

    Version of Record online : 31 AUG 2015, DOI: 10.1111/jsm.12980

  4. You have free access to this content
    Citalopram versus other anti-depressive agents for depression

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Marianna Purgato, Toshi A Furukawa, Carlotta Trespidi, Giuseppe Imperadore, Alessandra Signoretti, Rachel Churchill, Norio Watanabe and Corrado Barbui

    Published Online : 11 JUL 2012, DOI: 10.1002/14651858.CD006534.pub2

  5. The Role of the Two-Pore Domain Potassium Channel TREK-1 in the Therapeutic Effects of Escitalopram in a Rat Model of Poststroke Depression

    CNS Neuroscience & Therapeutics

    Volume 21, Issue 6, June 2015, Pages: 504–512, Dai-Hua Lin, Xiang-Rong Zhang, Dong-Qing Ye, Guang-Jun Xi, Jiao-Jie Hui, Shan-Shan Liu, Lin-Jiang Li and Zhi-Jun Zhang

    Version of Record online : 10 FEB 2015, DOI: 10.1111/cns.12384

  6. Glycine and a Glycine Dehydrogenase (GLDC) SNP as Citalopram/Escitalopram Response Biomarkers in Depression: Pharmacometabolomics-Informed Pharmacogenomics

    Clinical Pharmacology & Therapeutics

    Volume 89, Issue 1, January 2011, Pages: 97–104, Y Ji, S Hebbring, H Zhu, G D Jenkins, J Biernacka, K Snyder, M Drews, O Fiehn, Z Zeng, D Schaid, D A Mrazek, R Kaddurah-Daouk and R M Weinshilboum

    Version of Record online : 24 NOV 2010, DOI: 10.1038/clpt.2010.250

  7. You have free access to this content
    Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice

    British Journal of Pharmacology

    Volume 168, Issue 1, January 2013, Pages: 103–116, Hai T Nguyen, Bruno P Guiard, Alexandre Bacq, Denis J David, Indira David, Gaël Quesseveur, Sophie Gautron, Connie Sanchez and Alain M Gardier

    Version of Record online : 18 DEC 2012, DOI: 10.1111/j.1476-5381.2012.01850.x

  8. Female Sexual Dysfunction in Patients Treated with Antidepressant—Comparison between Escitalopram and Fluoxetine

    The Journal of Sexual Medicine

    Volume 9, Issue 5, May 2012, Pages: 1392–1399, Hatta Sidi, Duni Asmidar, Rozita Hod and Ng Chong Guan

    Version of Record online : 7 APR 2011, DOI: 10.1111/j.1743-6109.2011.02256.x

  9. You have free access to this content
    Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF)

    European Journal of Heart Failure

    Volume 9, Issue 12, December 2007, Pages: 1212–1222, Christiane E. Angermann, Götz Gelbrich, Stefan Störk, Andreas Fallgatter, Jürgen Deckert, Hermann Faller, Georg Ertl and on behalf of the MOOD-HF Investigators

    Version of Record online : 11 DEC 2008, DOI: 10.1016/j.ejheart.2007.10.005

  10. You have free access to this content
    Agomelatine versus other antidepressive agents for major depression

    Intervention Review

    The Cochrane Library

    Giuseppe Guaiana, Sumeet Gupta, Debbie Chiodo, Simon JC Davies, Katja Haederle and Markus Koesters

    Published Online : 17 DEC 2013, DOI: 10.1002/14651858.CD008851.pub2

  11. Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study

    Depression and Anxiety

    Volume 19, Issue 4, 2004, Pages: 241–248, Malcolm Lader, Karina Stender, Vera Bürger and Rico Nil

    Version of Record online : 11 JUN 2004, DOI: 10.1002/da.20014

  12. Restless Legs Syndrome Induced by Escitalopram: Case Report and Review of the Literature

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 2, February 2008, Pages: 271–280, Dr. Robert Lee Page II, Dr. J. Mark Ruscin, Dr. Jacquelyn L. Bainbridge and Dr. Andreas A. Brieke

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.2.271

  13. You have free access to this content
    Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population

    Depression and Anxiety

    Volume 25, Issue 1, January 2008, Pages: 46–54, Pei-xian Mao, Yi-lang Tang, Feng Jiang, Liang Shu, Xiuling Gu, Ming Li, Mincai Qian, Cui Ma, Philip B. Mitchell and Zhuo-ji Cai

    Version of Record online : 5 DEC 2006, DOI: 10.1002/da.20222

  14. Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria

    Human Psychopharmacology: Clinical and Experimental

    Volume 22, Issue 4, June 2007, Pages: 245–251, Dietmar Winkler, Edda Pjrek, Ulrike Moser and Siegfried Kasper

    Version of Record online : 18 APR 2007, DOI: 10.1002/hup.839

  15. You have free access to this content
    Research Podium Abstracts

    Value in Health

    Volume 12, Issue 3, May 2009, Pages: A1–A19,

    Version of Record online : 15 APR 2009, DOI: 10.1111/j.1524-4733.2009.00537_1.x

  16. Escitalopram in clinical practice: Results of an open-label trial in a naturalistic setting

    Depression and Anxiety

    Volume 21, Issue 1, 2005, Pages: 26–32, A. John Rush and Anjana Bose

    Version of Record online : 22 MAR 2005, DOI: 10.1002/da.20051

  17. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro

    CNS Neuroscience & Therapeutics

    Ouissame Mnie-Filali, Thorsten Lau, Friederike Matthaeus, Erika Abrial, Sarah Delcourte, Mostafa El Mansari, Alan Pershon, Patrick Schloss, Connie Sánchez and Nasser Haddjeri

    Version of Record online : 12 MAY 2016, DOI: 10.1111/cns.12562

  18. Duloxetine and escitalopram for hot flushes: efficacy and compliance in breast cancer survivors

    European Journal of Cancer Care

    N. Biglia, V.E. Bounous, T. Susini, S. Pecchio, L.G. Sgro, V. Tuninetti and R. Torta

    Version of Record online : 3 MAR 2016, DOI: 10.1111/ecc.12484

  19. You have full text access to this OnlineOpen article
    Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine – a quantitative EEG study in rats

    British Journal of Pharmacology

    Volume 171, Issue 18, September 2014, Pages: 4255–4272, S C Leiser, A L Pehrson, P J Robichaud and C Sanchez

    Version of Record online : 28 AUG 2014, DOI: 10.1111/bph.12782

  20. The Effect of Reporting Methods for Dosing Times on the Estimation of Pharmacokinetic Parameters of Escitalopram

    The Journal of Clinical Pharmacology

    Volume 49, Issue 2, February 2009, Pages: 176–184, Ms Yuyan Jin, Dr Bruce G. Pollock, Dr Ellen Frank, Dr Jeff Florian, Ms Margaret Kirshner, Dr Andrea Fagiolini, Dr David J. Kupfer, Dr Marc R. Gastonguay, Ms Gail Kepple, Dr Yan Feng and Dr Robert R. Bies

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008327538